Globus Medical (GMED)
Pretax margin
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Earnings before tax but after interest (EBT) | US$ in thousands | 165,393 | 243,019 | 180,407 | 125,899 | 189,946 |
Revenue | US$ in thousands | 1,568,480 | 1,022,840 | 958,102 | 789,042 | 785,368 |
Pretax margin | 10.54% | 23.76% | 18.83% | 15.96% | 24.19% |
December 31, 2023 calculation
Pretax margin = EBT ÷ Revenue
= $165,393K ÷ $1,568,480K
= 10.54%
The pretax margin of Globus Medical Inc has shown fluctuation over the past five years. The trend indicates a decrease from 24.19% in 2019 to 10.54% in 2023. The pretax margin peaked in 2022 at 23.76%, followed by a slight decline in 2023. This suggests that the company's ability to generate profit before taxes relative to its revenue has varied over the period analyzed. Further analysis and context would be needed to understand the specific factors driving these fluctuations and assess the overall financial performance of Globus Medical Inc.
Peer comparison
Dec 31, 2023
Company name
Symbol
Pretax margin
Globus Medical
GMED
10.54%
3M Company
MMM
-29.64%
Artivion Inc
AORT
-6.52%
Baxter International Inc
BAX
17.66%
Becton Dickinson and Company
BDX
8.34%
Boston Scientific Corp
BSX
14.20%
DexCom Inc
DXCM
19.72%
Embecta Corp
EMBC
9.51%
Glaukos Corp
GKOS
-44.40%
Haemonetics Corporation
HAE
5.85%
ICU Medical Inc
ICUI
-3.47%